Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Germany’s Merck KGaA has agreed to buy SpringWorks Therapeutics, adding the US biotech’s portfolio of cancer and rare disease ...

But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. Everyone has their own methods for finding great value opportunities, but ...

Banking will soon replace biotech just off Route 3 in Rockland, as Rockland Trust consolidates several of its offices south ...

The health sector is abuzz with significant news: from FDA approvals of novel drugs and mergers like Merck's acquisition of ...

A nylon maker goes bankrupt, a carbon capture start-up raises money, Germany’s Merck acquires SpringWorks, and more ...

Merck, the Pharma giant with operations in Lansdale, announced on Tuesday that it will build a $1 billion “biologics center ...

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders ...

Analysis by Product Type, Application, Technology, End User, and Region - Growth Trends and Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. The global lateral flow assay ...

In a deal that could top $1 billion, Merck & Co has teamed up with US biotech Janux Therapeutics to bring T-cell immunotherapies to cancer patients. The agreement sees San Diego-based Janux in ...

Young minds will get a chance to dive into artificial intelligence and hands-on science as MilliporeSigma's mobile lab, the ...

Merck shares dipped 0.1% following a stock sale by SVP Dalton E. Smart III, who offloaded over 4,200 shares worth roughly ...